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Abstract
Background: Leptin and insulin are long-term regulators of body weight. They act in hypothalamic centres to
modulate the function of specific neuronal subtypes, by altering transcriptional control of releasable peptides and
by modifying neuronal electrical activity. A key cellular signalling intermediate, implicated in control of food intake
by these hormones, is the enzyme phosphoinositide 3-kinase. In this study we have explored further the linkage
between this enzyme and other cellular mediators of leptin and insulin action on rat arcuate nucleus neurones
and the mouse hypothalamic cell line, GT1-7.
Results: Leptin and insulin increased the levels of various phosphorylated signalling intermediates, associated with
the JAK2-STAT3, MAPK and PI3K cascades in the arcuate nucleus. Inhibitors of PI3K were shown to reduce the
hormone driven phosphorylation through the PI3K and MAPK pathways. Using isolated arcuate neurones, leptin
and insulin were demonstrated to increase the activity of KATP channels in a PI3K dependent manner, and to
increase levels of PtdIns(3,4,5)P3. KATP activation by these hormones in arcuate neurones was also sensitive to the
presence of the actin filament stabilising toxin, jasplakinolide. Using confocal imaging of fluorescently labelled actin
and direct analysis of G- and F-actin concentration in GT1-7 cells, leptin was demonstrated directly to induce a
re-organization of cellular actin, by increasing levels of globular actin at the expense of filamentous actin in a PI3-
kinase dependent manner. Leptin stimulated PI3-kinase activity in GT1-7 cells and an increase in PtdIns(3,4,5)P3
could be detected, which was prevented by PI3K inhibitors.
Conclusions: Leptin and insulin mediated phosphorylation of cellular signalling intermediates and of KATP channel
activation in arcuate neurones is sensitive to PI3K inhibition, thus strengthening further the likely importance of
this enzyme in leptin and insulin mediated energy homeostasis control. The sensitivity of leptin and insulin
stimulation of KATP channel opening in arcuate neurones to jasplakinolide indicates that cytoskeletal remodelling
may be an important contributor to the cellular signalling mechanisms of these hormones in hypothalamic
neurones. This hypothesis is reinforced by the finding that leptin induces actin filament depolymerization, in a PI3K
dependent manner in a mouse hypothalamic cell line.
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Background
Leptin and insulin function as peripherally-derived hor-
mone signals involved in the long-term regulation of
energy balance [1-4]. Their circulating levels are directly
proportional to adipose mass and CNS access occurs via
saturable receptor-mediated processes. The primary CNS
target for these adipostats is the ARC, where leptin and
insulin receptors are highly expressed, and where direct
administration of either hormone has a potent effect on
food intake and body weight. Two specific ARC neurone
populations have been strongly implicated in sensing
changes in levels of circulating leptin and insulin and
transducing these signals into neuronal outputs [1,3].
These "first-order" neurones encompass the melanocortin
precursor, POMC containing neurones and NPY and
AgRP co-containing neurones, the former associated with
catabolic, the latter anabolic, outputs. Leptin and insulin
increase POMC mRNA levels and decrease NPY & AgRP
mRNA levels respectively.
However, transcriptional control is not the only effector
mechanism elicited by these hormones on ARC neurones.
Electrophysiological studies have shown that leptin depo-
larizes and increases the firing rate of ARC POMC neu-
rones and inhibits the tone of NPY/AgRP neurones [5].
Although the electrophysiological actions of insulin have
not been reported for identified POMC and NPY/AgRP
neurones, both leptin and insulin have been demon-
strated to inhibit, by hyperpolarization, the firing of a sub-
population of ARC neurones, identified by their sensitiv-
ity to changes in extracellular glucose concentration [6,7].
For these latter neurones, termed glucose-responsive
(GR), KATP channels have been identified as an effector
mechanism through which leptin and insulin elicit neuro-
nal inhibition. Consequently, leptin and insulin signal
the status of body energy stores by activating their recep-
tors on ARC neurones, eliciting changes in the electrical
activity and amounts of releasable peptides in specific
neuronal populations, leading to compensatory effector
outputs, such as changes in food intake, energy balance
and glucose homeostasis [8].
Obese humans have elevated leptin and insulin levels,
indicative of central resistance to these hormones [9]. The
mechanisms underlying this resistance are unclear, with
defective hormone passage through the BBB and flawed
receptor-signal transduction in ARC neurones being the
prime candidates [10,11]. Consequently, it is important
to understand the molecular mechanisms underlying lep-
tin and insulin receptor modulation of ARC first-order
neurones. Leptin and insulin, by stimulation of their
respective receptors, have been demonstrated to activate
various signalling pathways in peripheral tissues [10-13].
However, as these hormones induce seemingly identical
actions on ARC neurones, both in terms of behavioural
output and effects on ARC neurone excitability, some par-
allelism or convergence of signalling is likely [12,13]. Lep-
tin, by binding to the long form of the leptin receptor
(ObRb) has been demonstrated to activate three main sig-
nalling cascades, JAK2 – STAT3, MAPK and PI3K, the latter
two of which are also intermediates in insulin receptor
activation [14,15]. However, recent studies have strongly
implicated PI3K as the key signalling intermediate in lep-
tin and insulin actions on hypothalamic neurones influ-
encing food intake and body weight [16,17].
Thus, to elucidate further the pathways that contribute to
convergent actions of leptin and insulin on ARC neu-
rones, we have examined the phosphorylation status of
key leptin and insulin signalling intermediates in the ARC
and have explored the linkage, with a focus on PI3K medi-
ated signal transduction pathways, between these hor-
mones and ARC neurone KATP channel activation.
Results
Leptin and insulin stimulate phosphorylation of signalling 
proteins in ARC
Rat hypothalamic tissue sections, predominantly made up
of arcuate nucleus, were treated with aCSF alone or with
leptin (10 nM) or insulin (0.1 or 1 nM, which produced
identical results) for 1, 5, 15 and 30 minutes. Leptin and
insulin stimulation induced comparable immunoblot
profiles (Figure 1), with increased levels of phosphor-
ylated STAT3 (p-STAT3), phosphorylated MAPK (p-
MAPK), phosphorylated PKB/Akt (p-PKB) and GSK3 (p-
GSK3). The phosphorylation status of the latter two pro-
teins, PKB and its downstream effector GSK3, were uti-
lised as a sensitive assay for hormone activation of PI3K.
Leptin (10 nM) or insulin (0.1 nM) treatment was
observed to cause an increase in phosphorylation of all
four proteins. This increase in phosphorylation was gener-
ally transient with the highest levels of phosphorylation at
the 1 and/or 5 minute time points. Subsequent to this
peak level, in the majority of experiments, the phosphor-
ylation was not sustained over the time period examined
and returned to control values within 30 minutes (Figure
1A,1B). These data demonstrate that all 3 pathways poten-
tially contribute to insulin and leptin signalling in ARC
neurones and thus play a role in connecting leptin or insu-
lin receptor activation to neuronal effector outputs. As
both leptin and insulin signalling in the ARC require PI3K
activity for reduction in food intake and body weight
[16,17], we examined the sensitivity of the phosphoryla-
tion of PKB/GSK3 and MAPK to the presence of PI3K
inhibitors. Isolated ARC sections were incubated either in
control aCSF, 10 nM wortmannin or 10 PM LY294002,
for 20 minutes prior to exposure to control aCSF, leptin
(10 nM) or insulin (0.1 nM), in the continued presence of
the appropriate inhibitor. The presence of LY294002 pre-
vented leptin or insulin induced phosphorylation of PKB
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and GSK3 following 1 minute exposure to these hor-
mones, illustrated in Figure 2A, as expected for proteins
downstream of PI3K [18]. Furthermore, the presence of
the PI3K inhibitor per se reduced p-PKB and p-GSK3 levels
significantly, indicating that PI3K is active to a limited
degree in these ARC neurones. Similar results were
obtained for wortmannin (data not shown). However,
surprisingly the PI3K inhibitors also reduced the leptin-
and insulin-stimulated phosphorylation of MAPK (Figure
2B). These data further establish PI3K as a key component
of neuronal leptin and insulin signalling in ARC neurones
and suggest a potential role for PI3K in leptin and insulin
driven transcriptional activity. Because the phosphoryla-
tion status of these signalling intermediates was examined
in whole ARC extracts, this supplies little information as
to the mechanisms by which adiposity hormones target
specific ARC neurones. Thus, we have tried to delineate
the molecular events connecting leptin and insulin recep-
Effects of leptin and insulin on phosphorylation of STAT3, MAPK, PKB and GSK3Figure 1
Effects of leptin and insulin on phosphorylation of STAT3, MAPK, PKB and GSK3 Rat ARC wedges were incubated 
for 0, 1, 5, 15 or 30 minutes with 10 nM leptin (A) or 0.1 – 1 nM insulin (B) before cells were lysed and equal amounts of lysate 
were subjected to SDS-PAGE and transferred to nitrocellulose membrane. The phosphorylated levels of p42/p44 MAPK, PKB, 
STAT3 and GSK3D/E were detected by immunoblotting with appropriate specific antibodies. The total amount of PKB is also 
shown. Bands were quantified using densitometry. The values are expressed as relative to the corresponding aCSF control 
group, and normalized for protein loading. Values represent the mean ± SEM for between 4–6 animals for each time point. * P 
< 0.05 and ** P < 0.01.
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tor activation, PI3K activity and effector outputs. Here we
focus on the activation of KATP channels, responsible for
leptin and insulin inhibition of an electrophysiologically
identified subset of ARC neurones [6,7].
Leptin and insulin activate KATP channels in acutely 
isolated ARC neurones
Cell-attached recordings from rat isolated ARC neurones
were used to confirm that leptin and insulin activate the
Changes in phosphorylation of PKB, GSK3 and MAPK by inhibition of PI3KFigur  2
Changes in phosphorylation of PKB, GSK3 and MAPK by inhibition of PI3K Rat ARC wedges were pretreated with 
10 PM LY294002 or aCSF for 20 minutes and incubated for 1 minute with 10 nM leptin or 1 nM insulin or aCSF. Equal amounts 
of protein lysate were subjected to SDS-PAGE and transferred to nitrocellulose membrane. The phosphorylated levels of PKB, 
and GSK3DE (A) and p42/p44 MAPK (B) were detected by immunoblotting with appropriate specific antibodies. The total 
amount of PKB is also shown. Bands were quantified using a densitometer. The values are expressed as relative to the corre-
sponding aCSF control group, and normalized for protein loading. Values represent the mean ± SEM for between 4–5 and 3–5 
animals for each time point with leptin and insulin respectively. * P < 0.05 and ** P < 0.01.
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large conductance KATP channel as previously described
[6,7]. Leptin, present in the recording electrode during
cell-attached recordings, increased mean K+ channel activ-
ity in 45% of unidentified neurones (n = 25/55). Mean
channel activity (Nf.Po), 1–2 minutes following cell
attached formation was 0.08 ± 0.02 and increased to 0.38
± 0.03 (n = 10, P < 0.01) after peak activation had
occurred (10.6 ± 1.0 minutes after patch formation). In
control cell-attached recordings of between 10–25 min-
utes, with 10 nM leptin in the pipette solution, there was
no effect on K+ channel currents observed in other ARC
neurones (n = 30). During peak KATP channel activation by
Leptin and insulin activate large conductance KATP in ARC neuronesFigure 3
Leptin and insulin activate large conductance KATP in ARC neurones A, representative cell-attached recording from 
an acutely dissociated ARC neurone. Leptin (10 nM), present in the electrode solution, increased the activity of a K+ channel, 
which was inhibited reversibly by bath application of 200 PM tolbutamide. Upward deflections in this and subsequent cell-
attached recordings are extracellularly recorded action current activity. B, representative recording from an inside-out patch 
under asymmetrical K+ conditions and held at 0 mV obtained from an acutely dispersed ARC neurone, following cell-attached 
leptin-induced increase in channel activity. Note that bath application of 3 mM MgATP reversibly inhibited K+ channel activity. 
Inserts are expanded regions of traces showing channel activity in more detail. C, representative cell-attached recording from 
an acutely dissociated ARC neurone. Under control conditions, few channel openings are observed. Subsequent to bath appli-
cation of 0.1 nM insulin, there is a marked increase in KATP channel activity. Corresponding diary plot of channel activity (Nf.Po) 
with time displays the insulin induced increase in activity.
A B
C
30 mins: 10 nM Leptin
20 mins: 10 nM Leptin + 200 µM Tolbutamide
c>
c>
c>
c>
15 mins: 10 nM Leptin
0 mins: 10 nM Leptin
10 pA
1 s
0.1 nM Insulin 10 minutes
Control
c>
c>
1 s
10 pA 0 10 20 30
0.25
0.50
0.75
Time (mins)
N
f.P
o
0.1 nM Insulin
Control
3 mM MgATP
Wash
c>
c>
c>
c>
c>
c>
2 s
(inserts 200 ms)
20 pA
(inserts 10 pA)
BMC Neuroscience 2004, 5:54 http://www.biomedcentral.com/1471-2202/5/54
Page 6 of 18
(page number not for citation purposes)
leptin, bath application of the KATP channel inhibitor tolb-
utamide (200 PM), reduced mean channel activity by 56
± 12% (n = 4; P < 0.05), an effect reversible on washout of
drug (Figure 3A). Following leptin-induced increase in
channel activity, patch excision into the inside-out config-
uration allowed channel sensitivity to ATP to be assessed.
At a patch potential of 0 mV and in asymmetric cation gra-
dients, mean channel activity was 0.40 ± 0.09 (n = 3) and
bath application of 3 mM MgATP (Figure 3B) reversibly
reduced channel activity by 67.1 ± 9.7% (P < 0.05). Cur-
rent-voltage relations under symmetrical K+ conditions
were linear, with a mean single channel conductance of
156 ± 15 pS (n = 3). The sensitivity to tolbutamide, ATP
and single channel characteristics are consistent with lep-
tin activation of the large conductance KATP channel of GR
neurones [6,19]. In a separate series of cell-attached
recordings from isolated ARC neurones, bath application
of insulin (0.1 – 10 nM) also increased KATP channel activ-
ity in 45% of unidentified neurones (n = 14/31). Nf.Po
increased from 0.14 ± 0.03 under control conditions to
0.49 ± 0.08 (n = 7; P < 0.01) after approximately 10 – 20
minutes exposure to insulin (Figure 3C). Insulin had no
effect on other K+ channel currents in cell-attached record-
ings from the remaining neurones (n = 17). Conse-
quently, these data are in agreement with previous studies
on rat ARC GR neurones [6,7].
Leptin and insulin activation of ARC neurone KATP is PI3K 
dependent
As leptin and insulin activation of KATP channels in ARC
neurones is rapid (<5–10 minutes) and the leptin increase
in KATP activity demonstrated in isolated patches [6], this
action is unlikely to be mediated by changes in transcrip-
tion. Furthermore, in cell-attached recordings, following
leptin (10 nM) stimulated KATP channel activity, applica-
tion of the MAPK pathway inhibitor, PD98059 (10 PM; n
= 4) had no effect on Nf.Po (Figure 4A). A previous study
has demonstrated that insulin activated ARC neurone
KATP channels are similarly insensitive to this MAPK path-
way inhibitor [7]. However, inhibition of PI3K does
reverse both leptin (Figure 4B) and insulin-induced acti-
vation of ARC neurone KATP channels. Leptin (10 nM)
increased KATP mean Nf.Po from 0.21 ± 0.10 to 0.68 ± 0.28
(n = 3, P < 0.02), and subsequent bath application of 10
nM wortmannin reduced KATP activity to a mean value of
0.33 ± 0.13 (n = 3, P < 0.02) over a period of 15–20 min-
utes, an Nf.Po indistinguishable from control (P > 0.4).
Similarly, in a separate series, leptin increased Nf.Po from
0.15 ± 0.04 to 0.35 ± 0.05 (n = 4, P < 0.05) and subse-
quent application of 10 PM LY294002 reduced Nf.Po to
0.19 ± 0.04 (n = 4, P < 0.01) within 15–20 minutes. Essen-
tially identical data have been reported previously for the
effects of these PI3K inhibitors on insulin-activated ARC
KATP channel activity [7]. Thus these results demonstrate
that leptin and insulin signalling pathways converge on
PI3K to elicit GR neurone hyperpolarization, and confirm
that PI3K is a key enzyme in individual ARC neurone
responsiveness to both leptin and insulin.
Such a central role for PI3K suggests that its main lipid
product, PtdIns(3,4,5)P3 may serve as an important sec-
ond messenger for downstream effectors such as the KATP
channel. The mechanism by which PtdIns(3,4,5)P3 recog-
nises downstream target proteins is by binding to special-
ised phosphatidylinositol recognition sites, such as the
pleckstrin homology (PH) domain [20]. Thus, to demon-
strate that PtdIns(3,4,5)P3 production is elevated in ARC
neurones following exposure to leptin and insulin, we
used the PH domain of GRP-1, which selectively binds
PtdIns(3,4,5)P3 [21] coupled to GFP (PH-GRP1-GFP) in
an overlay assay on fixed freshly isolated ARC neurones.
In non-stimulated ARC neurones there is significant label-
ling of all neurones with PH-GRP1-GFP (Figure 5). This is
likely due to inherent PI3K activity of the neurones, rather
than non-specific binding, as a PH-GRP1-GFP fusion pro-
tein with a single point mutation (K273A), which does
not bind PtdIns(3,4,5)P3 [21,22], displays very little reac-
tivity with non-stimulated ARC neurones (n = 7). Stimu-
lation of isolated ARC neurones with leptin (10 nM) for
10 minutes resulted in a proportion (38 ± 8%; n = 5) of
dispersed neurones displaying increased fluorescence
after treatment with wild type fusion protein (Figure 5A).
In addition, exposure of dispersed neurones to insulin (1
nM) for 5–10 minutes induced increased binding of PH-
GRP1-GFP fusion protein in a similar proportion of neu-
rones (43 ± 15%; n = 6), although insulin appeared to
induce greater levels of binding/fluorescence than leptin
(Figure 5B). However, leptin and insulin driven phospho-
rylation of PKB and GSK3 along with induction of ele-
vated PtdIns(3,4,5)P3 levels in ARC neurones, are only
indicative of increased PI3K activity. Thus we examined
IRS-2 associated PI3K activity [16] in isolated ARC wedges
exposed for one or two minutes to leptin (up to 50 nM)
or insulin (up to 100 nM). Although we observed an
increase in activity in 4/8 and 4/7 experiments for leptin
and insulin respectively, there was no overall significant
increase observed (data not shown). This may be due to
the relative paucity of leptin and /or insulin sensitive neu-
rones in the overall cellular population.
Leptin and insulin activation of GR neurone KATP requires 
actin filament re-organisation
Previous studies have demonstrated that the phosphati-
dylinositol lipid second messenger, PtdIns(3,4,5)P3 acti-
vates KATP channels in an insulin-secreting cell line when
applied directly to the internal aspect of isolated patches
[23]. However, activation of KATP is probably not due to
direct binding of the lipid to channel subunits, as the
effect of PtdIns(3,4,5)P3 on KATP was prevented by the
presence of the actin stabilizing agent, phalloidin.
BMC Neuroscience 2004, 5:54 http://www.biomedcentral.com/1471-2202/5/54
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Additionally, leptin-induced opening of this insulin-
secreting cell KATP channel was occluded when phalloidin
was present in the cell interior [23]. Thus we examined
whether adiposity hormone signalling in ARC GR neu-
rones also requires actin remodelling in order to manifest
a specific effector output, the activation of hypothalamic
neurone KATP channels. As our assessment of hormone
activation of GR neurone KATP channels uses cell-attached
recordings, we used the membrane permeable actin stabi-
lizing toxin, jasplakinolide to induce actin polymeriza-
tion [24]. In preliminary experiments, jasplakinolide (100
nM) was demonstrated to have no effect when applied
directly to isolated inside-out patches obtained from ARC
neurones, under asymmetrical recording conditions, con-
taining spontaneously active KATP channels (n = 4; P > 0.5;
data not shown). Cell-attached recordings with leptin (10
nM) present in the pipette solution, increased mean KATP
channel activity from 0.07 ± 0.02 to 0.44 ± 0.07 (n = 4; P
< 0.01). Subsequent bath application of jasplakinolide
(50 – 100 nM) reversed the leptin-induced KATP activation
(Figure 6A), with channel activity returning to 0.10 ± 0.02
(n = 4; P < 0.01) within 5–10 minutes, a level indistin-
guishable from pre-leptin controls (P > 0.5). In a second
series of cell-attached recordings, bath application of insu-
lin (0.1 – 10 nM) increased mean KATP activity from 0.06
± 0.01 to 0.64 ± 0.16 (n = 4; P < 0.01) and subsequent
bath application of jasplakinolide (100 nM), in the con-
tinuous presence of insulin, reduced channel activity to
PI3K activity mediates leptin activation of KATPFigure 4
PI3K activity mediates leptin activation of KATP Representative cell-attached recordings with leptin (10 nM), present in 
the recording electrode. A, traces illustrate that leptin-induced increase in KATP activity is not reversed on bath application of 
the MEK inhibitor, PD 98059 (50 PM). The corresponding diary plot for part of the recording, initiated 20 mins after recording 
began, and following attainment of maximal leptin-induced KATP channel activity is shown. B, traces show that leptin-induced 
KATP channel activity is inhibited by subsequent application of the PI3K inhibitors, wortmannin (10 nM) or LY294002 (10 PM). 
Corresponding diary plots for Nf.Po from a single experiment for each PI3K inhibitor are shown below the relevant traces.
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Leptin and insulin increase PtdIns(3,4,5)P3in isolated neuronesFigure 5
Leptin and insulin increase PtdIns(3,4,5)P3 in isolated neurones Acutely isolated ARC neurones were incubated in the 
absence and presence of 10 nM leptin (A) or 1 nM insulin (B) for 10 minutes. Cells were fixed and permeabilized, as described 
in Methods, prior to incubation with wild type (wt) or K273A mutant (mt) PH-GRP1-GFP fusion protein for 1 hour. Cells were 
subsequently processed for visualising GFP by confocal microscopy. Note that leptin and insulin increased the binding of wild 
type PH-GRP1-GFP in ARC neurones, and this is shown as both the fluorescence image (upper panels in A, B) and as a false 
colour image (lower panels in A, B), where blue represents low or non-detectable fluorescence and red the highest fluores-
cence intensity.
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0.17 ± 0.06 (n = 4; P < 0.01) within 5–10 minutes (Figure
6B). The inhibition of leptin and insulin stimulated KATP
channel activity by jasplakinolide was reversible on wash-
out of the toxin in 2/4 and 3/4 patches for leptin and insu-
lin respectively.
PI3K mediates leptin-induced actin filament 
reorganisation in GT1-7 cells
Preliminary experiments labelling rat ARC slices with
rhodamine-conjugated phalloidin to stain for F-actin
were unsatisfactory due to the overall high levels of
staining in the slices and inability to distinguish clearly
individual neurones and their responses to hormone
stimulation. Similarly, use of freshly isolated ARC neu-
rones was precluded as the phalloidin staining was
inconsistent among individual neurones within a single
preparation and between neuronal preparations. Thus we
have used the mouse hypothalamic cell line, GT1-7, to
demonstrate that leptin utilises a PI3K-dependent signal-
ling cascade to modify cytoskeletal dynamics. A previous
study indicated that GT1-7 cells express ObRb [25],
although others do not concur with this conclusion [26].
Using RT-PCR, we detected the presence of leptin receptor
mRNA in GT1-7 cells by amplification of a common extra-
cellular domain of the mouse receptor. Further analysis
using primers specific to ObRb, which contains a long
cytosolic domain with the intracellular protein motifs
required for signalling [10], demonstrates the presence of
Actin dynamics mediate leptin and insulin activation of KATPFigure 6
Actin dynamics mediate leptin and insulin activation of KATP A, representative cell-attached recording from an acutely 
isolated ARC neurone with leptin (10 nM) in the electrode solution. Following attainment of increased KATP activity, bath appli-
cation of jasplakinolide (100 nM) reversibly reduced channel activity. The corresponding diary plot for this experiment is 
shown. B, representative cell-attached recording from an ARC neurone. Bath application of insulin (10 nM) increased KATP 
channel activity and subsequent bath addition of 100 nM jasplakinolide, concomitant with 10 nM insulin, reversibly inhibited the 
insulin stimulated KATP activity. The corresponding diary plot is shown.
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this receptor isoform in GT1-7 cells (Figure 7A). We have
also used this hypothalamic cell line to examine whether
leptin is capable of increasing PI3K activity directly. In
response to 50 nM leptin, IRS-2-associated PI3K activity
was modestly, but significantly, increased (Figure 7B).
Thus, using native GT1-7 cells leptin (1–10 nM) induced
a decrease in cortical F-actin as visualised by alexa 488
conjugated phalloidin staining, which was prevented or
reversed by the presence of 100 nM jasplakinolide (n = 8;
Figure 8 upper panels). As cellular cortical actin structure
is determined by the dynamic equilibrium between F- and
G-actin, a reduction in F-actin at the plasma membrane
should be accompanied by a corresponding increase in
the concentration of free G-actin in the cells [27]. Figure 8
(middle panel) demonstrates, using alexa 594 conjugated
DNase I staining of the same cells, that leptin does indeed
increase the concentration of G-actin and that this effect is
also sensitive to the presence of jasplakinolide (n = 8).
Indeed, dual staining of the GT1-7 cells demonstrates
(Figure 8, lower panel) that leptin alteration of the cortical
cytoskeleton is due to a concomitant increase in the con-
tent of G-actin at the expense of F-actin, and that this
action is completely inhibited in the presence of jasplaki-
nolide. The alteration in cytoskeletal dynamics by leptin is
also PI3K dependent as shown in Figure 9A, where the
presence of either 10 nM wortmannin (n = 13) or 10 PM
LY294002 (n = 13) substantially reduced the ability of
leptin to decrease the levels of F-actin and increase G-actin
as assessed by phalloidin and DNase I staining respec-
tively. This cell staining method of assessing leptin stimu-
lated changes in actin dynamics was compared to direct
quantitative analysis of actin. Live cells were treated with
leptin (10 nM) ± jasplakinolide (100 nM) or LY294002
(10 PM) or wortmannin (10 nM) for 20 minutes, Triton-
X-100 soluble (G) and insoluble (F) actin fractions sepa-
rated and run on a gel [28]. Exposure of cells to leptin did
not alter total cellular actin, whereas G-actin levels
increased by 2 fold, at the expense of F-actin, the levels of
which declined by 65% (n = 4; Figure 9C,9D). Thus, lep-
tin induced a change in the G/F actin ratio from a control
value of 0.54 to 3.17. These data correlate well with the
change in fluorescence intensity observed in leptin-treated
fixed cells (n = 8), where G-actin levels were also increased
by 2 fold and F-actin decreased by 70% (Figure 9B). Expo-
Leptin stimulates PI3K activity in GT1-7 cellsFigure 7
Leptin stimulates PI3K activity in GT1-7 cells A, expression of the leptin receptor mRNA in mouse GT1-7 cells. Lanes 
1–3, RT-PCR detection of the common ObR isoform in hypothalamus (lane 2) and GT1-7 cells (lane 3), together with a nega-
tive control (lane 1). Lanes 4–6, RT-PCR detection of the ObRb isoform in the hypothalamus (lane 5) and GT1-7 cells (lane 6) 
together with a negative control (lane 4). Note the presence of PCR products of the appropriate sizes in GT1-7 and hypotha-
lamus (465 bp ObR and 647 bp ObRb). B, PI3K activity associated with IRS-2 in GT1-7 cells stimulated with 50 nM leptin. PI3K 
activity was measured in immunoprecipitates and was quantitated using a Phosphoimager. Data are mean ± SEM for 4 experi-
ments. ** P < 0.01.
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sure of cells to the F-actin stabilizing agent, jasplakinolide
or the PI3K inhibitors, LY294002 or wortmannin pre-
vented leptin from inducing F-actin disassembly as
observed by either assay (Figure 9A,9B,9C,9D). In addi-
tion, protein overlay experiments using wild type PH-
GRP1-GFP fusion protein binding to assess
PtdIns(3,4,5)P3 levels in GT1-7 cells demonstrate that lep-
tin increases PI3K activity concurrently with the re-organ-
ization of cortical actin in this cell line, with leptin
stimulation inducing little change in the K273A mutant
PH-GRP1-GFP binding to these cells (Figure 10).
Discussion
PI3K – a pivotal enzyme in ARC signalling
Previous studies have demonstrated that leptin applied in
vivo stimulates hypothalamic ObRb to increase phospho-
rylation of the signalling protein intermediates STAT3 and
MAPK and that both leptin and insulin increase
Leptin disrupts cortical actin filaments in GT1-7 cellsFigure 8
Leptin disrupts cortical actin filaments in GT1-7 cells Cultured GT1-7 cells were incubated in the absence and pres-
ence of leptin (10 nM) ± jasplakinolide (100 nM) for 30 minutes (jasplakinolide added 10 minutes prior to leptin). Following 
treatment cells were fixed and permeabilized, as described in the Methods, incubated with Alexa 488 conjugated phalloidin and 
Alexa 594 conjugated DNase I and subsequently processed for visualising F- and G-actin respectively by confocal microscopy.
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hypothalamic PI3K activity [12,29]. Here we have applied
hormones directly to ARC wedges isolated from hypotha-
lamic slices to enable improved signal detection (with
respect to amplitude and temporal resolution), localisa-
tion of signalling to the arcuate nucleus and to fix external
conditions so that potential compensatory changes asso-
ciated with in vivo studies are obviated. Exposure of ARC
wedges to leptin or insulin induced rapid (d1 minute)
phosphorylation of MAPK (ERK1 & 2 subfamilies), STAT3
and the PI3K activity indicators, PKB and its downstream
target GSK3. These hormone-induced increases in phos-
phorylation were transient in the majority of experiments,
usually lasting 1–5 minutes at ~34°C with return to con-
trol levels of phosphorylation within 30 minutes. Such
rapid recovery has also been noted in other studies
[13,30] and may be due to activation of endogenous
PI3K mediates F-actin disruption in GT1-7 cellsFigure 9
PI3K mediates F-actin disruption in GT1-7 cells A, Cultured GT1-7 cells were incubated in the absence and presence of 
leptin (10 nM) ± wortmannin (10 nM) or LY 294002 (10 PM) for 30 minutes. Following treatment cells were fixed and perme-
abilized, as described in the Methods, incubated with Alexa 488 conjugated phalloidin and Alexa 594 conjugated DNase I and 
subsequently processed for visualising F- and G-actin respectively by confocal microscopy. B, Plot of average alexa 488-phalloi-
din fluorescence intensity (green) and alexa 594-DNase 1 (red) in fixed cells treated with 10 nM leptin (L) alone or cells treated 
with leptin and jasplakinolide (100 nM; J + L), LY294002 (10 PM; L + L) or wortmannin (10 nM; W + L) relative to cells 
untreated (C) with drug (n = 8 separate experiments, with 8 cells measured under each condition for each experiment). C, 
GT1-7 cells were incubated with PBS only (C), 10 nM leptin (L) or leptin and jasplakinolide (100 nM; J + L), LY294002 (10 PM; 
L + L) or wortmannin (10 nM; W + L). Cells were treated to extract actin pools as described in Methods and equal amounts of 
pool lysate were subjected to SDS-PAGE and transferred to nitrocellulose membrane. The levels of actin were detected by 
immunoblotting with an actin monoclonal antibody. D, Plot of average Triton-X-100 soluble (G, red), Triton-X-100 insoluble 
(F, green) and total actin (gray) concentration from live cells, relative to control untreated cells (n = 4 separate experiments), 
for data as shown in C. Error bars indicate s.e.m. and * significance of P < 0.01.
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phosphatases such as PTP1B curtailing this acute signal-
ling process [14,31]. The phosphorylation of MAPK is
quite modest and at present there are few data which link
this pathway directly with the actions of either insulin
[32] or leptin [16] on energy homeostasis, although
recently it has been shown that centrally driven insulin-
mediated sympathoactivation of brown adipose tissue is
MAPK-dependent [33].
As expected, exposure of ARC wedges to leptin induced an
increase in tyrosine phosphorylated STAT3 [11,13,29,34].
However, unexpectedly insulin also induced an increase
in tyrosine phosphorylation of STAT3 in ARC neurones.
In a previous study [30] in vivo application of insulin (icv)
demonstrated no such change, unless leptin was co-
applied. The data reported here indicate that insulin per se
is capable of increasing STAT3 phosphorylation, as no
exogenous leptin was present or endogenous leptin likely
to remain in the ARC sections following the extensive
washes and incubations prior to stimulation. This differ-
ence may be due to an increased signal to noise delivered
using ARC tissue over whole hypothalamus and that rapid
transient signals are more readily detectable by this
method. Both leptin and insulin rapidly increased the
phosphorylation of PKB and its downstream effector
GSK3 in a wortmannin and LY294002 sensitive manner,
indicative of increased PI3K activity in ARC neurones, in
agreement with previous in vivo studies [17,35].
However, our results did not demonstrate that either lep-
tin or insulin induced a significant increase in IRS-2-asso-
ciated PI3K activity measured directly in ARC tissue. This
may be due to a low signal to noise ratio, as only a
(unknown) proportion of cells would be expected to
respond to the hormones in the ARC tissue block, and/or
that hormone mediated increases in PI3K activity are lim-
ited to plasma membrane microdomains. This is sup-
ported by the very modest increase in PI3K activity
detected in GT1-7 cells when stimulated by leptin.
Although hypothalamic activation of PKB by insulin has
been reported previously [17], these are the first reports
that leptin increases PKB activity and that both hormones
increase the phosphorylation of GSK3 in the ARC. The
presence of the PI3K inhibitors, wortmannin or
LY294002, also reduced the leptin and insulin driven
increase in MAPK phosphorylation. The mechanism by
which leptin and insulin cause phosphorylation of this
protein is most likely through the Ras pathway, as this
protein has been demonstrated to interact directly with
the catalytic subunit of PI3K [36] and inhibitors of PI3K
Re-organisation of F-actin is associated with raised PtdIns(3,4,5)P3 levels in GT1-7 cellsFigu e 10
Re-organisation of F-actin is associated with raised PtdIns(3,4,5)P3 levels in GT1-7 cells Cultured GT1-7 cells were 
incubated in the absence and presence of 10 nM leptin for 20 minutes. Cells were fixed and permeabilized, as described in 
Methods, prior to incubation with rhodamine-conjugated phalloidin and wild type (wt) or K273A mutant (mt) PH-GRP1-GFP 
fusion protein for 60 minutes. Cells were subsequently processed for visualising GFP and rhodamine by confocal microscopy.
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have been reported to inhibit insulin induced increased
MAPK activity, for example in rat adipocytes [37]. The
insulin mediated enhanced STAT3 tyrosine phosphoryla-
tion in an interesting observation that requires further
examination. Although phosphorylation of tyrosine-705
on STAT3 is a prerequisite for dimerisation and transloca-
tion of STAT3 to the nucleus [38], phosphorylation of
serine-727 may also be required for maximal activation of
STAT3 DNA binding [39].
Interestingly one pathway candidate for phosphorylating
serine-727 is the Ras/Raf/MEK signalling cascade, and
indeed a recent study has demonstrated that leptin can
induce S727 phosphorylation of STAT3 in a PD98059
dependent manner in macrophages, and this is required
to produce full stimulation of STAT3 [40]. Insulin medi-
ated serine phosphorylation of STAT3 has also been
reported, using transfected Chinese hamster ovary cells, to
be mediated by a MEK-dependent pathway [41]. A similar
mechanism in hypothalamic neurones would indicate an
inter-connection between the three identified signalling
pathways activated by these hormones and an important
effector molecule, STAT3. Studies are underway to exam-
ine this proposal.
The importance of STAT3 signalling to the central mecha-
nisms that control energy homeostasis has recently been
directly demonstrated by transgenic mouse studies. Using
a 'knock-in' strategy to induce defective STAT3 binding to
ObRb [42] or a 'knock-out' strategy to ablate STAT3 from
some hypothalamic neurones [43], loss or reduction in
hypothalamic STAT3 signalling initiates hyperphagia,
increased body weight and adiposity with alterations in
glucose homeostasis. Indeed, the JAK2-STAT3 and IRS2-
PI3K signalling pathways are purported to underpin the
genomic and acute or membrane functions of these sig-
nalling pathways respectively [12]. Clearly, further work is
required to determine the exact signalling mechanisms
controlling insulin stimulated STAT3 phosphorylation in
hypothalamic neurones.
Leptin and insulin signalling to KATP channels
Leptin and insulin cause inhibition, by hyperpolarization
through activation of a sulphonylurea-sensitive K+ con-
ductance, of a subset of hypothalamic neurones, defined
by their acute sensitivity to changes in external glucose
concentration, termed GR neurones [6,7,19]. Single chan-
nel recordings from acutely isolated ARC neurones dem-
onstrate that both hormones activate the same K+ channel,
the sulphonylurea-sensitive large conductance KATP chan-
nel. This action is rapid and independent of
transcriptional events, so most likely is mediated by
MAPK or PI3K signalling. Pharmacological inhibition of
the MAPK pathway with PD98059 did not reverse leptin
(as shown above) or insulin [7] stimulated KATP activity,
abrogating this pathway from causing the hyperpolarising
response. In contrast, inhibition of PI3K with either wort-
mannin or LY294002, reversed both leptin (as shown
above) and insulin [7] raised KATP activity. Furthermore,
use of the fusion protein PH-GRP1-GFP as a specific detec-
tor of PtdIns(3,4,5)P3 in isolated neurones also demon-
strated that both hormones rapidly increase the cellular
content of this PI3K lipid product in a sub-population of
neurones. These results are consistent with class 1 PI3K
[44] acting as a point of convergence for leptin and insulin
signal transduction pathways to KATP channels in GR neu-
rones. The functional significance of PI3K in the control
of energy balance has been demonstrated by in vivo stud-
ies, which show that leptin [16] and insulin [17] stimulate
IRS2-associated PI3K activity in the hypothalamus and
pharmacological inhibition, using wortmannin and
LY294002, of hypothalamic PI3K activity prevents the
anorectic actions of icv leptin or insulin, whereas the
MAPK inhibitor PD98059 had no effect on leptin driven
attenuation of food intake [16].
Remodelling of cortical actin filaments as a leptin and 
insulin signalling event
Leptin and insulin stimulated KATP activity in isolated ARC
neurones was also reversed, within 5–10 minutes, by the
marine sponge toxin, jasplakinolide. This toxin binds to
F-actin with high affinity, resulting in its stabilization and
prevention of depolymerization to its monomer G-actin
[24]. These data indicate that the adiposity hormones
require actin filament depolymerization for KATP activa-
tion to occur. Such a mechanism is supported by reports
that agents, which promote actin depolymerization, acti-
vate KATP channels in cardiac myocytes [45,46] and the
insulin-secreting cell line, CRI-G1 [47]. Furthermore, in
this latter study leptin stimulated KATP channel activity
was also shown to depend on actin filament depolymeri-
zation. Insulin is also well documented to cause actin fil-
ament re-organization in peripheral cells associated with
various functional outputs, which depend on PI3K activ-
ity, including metabolic and mitogenic effects [48]. The
reversal of hormone-stimulated KATP activity by jasplaki-
nolide was faster (5–10 minutes) than for the PI3K inhib-
itors (15–20 minutes). This temporal difference suggests
that the site of jasplakinolide action is downstream from
the PI3K signal transduction pathway to KATP channels.
However, alteration of the cellular cortical actin structure
is inferred through the use of natural agents like jasplaki-
nolide. In order to verify directly that hormone-driven
structural re-arrangements did occur we decided to use the
hypothalamic cell line, GT1-7, as preliminary experiments
using freshly isolated neurones did not produce reliable
and reproducible data due to the presence of dead and
dying cells showing as false positives for hormone
induced actin depolymerization. Use of this cell line also
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obviated any problems with identification of ObRb con-
taining neurones and neuronal subtypes in slices. RT-PCR
analysis indicates that this cell line does express the main
signalling form of the leptin receptor and analysis of PI3K
activity shows functional coupling of this receptor to this
signalling pathway. We have shown, by cell staining of
fixed cells and, independently by analysis of cellular G-
and F-actin concentration from live cells, that leptin dis-
rupts cortical actin structure by disturbing the processes
that maintain the equilibrium between F-actin and G-
actin, in the direction of depolymerization to G-actin.
This effect of leptin was completely inhibited by the pres-
ence of either jasplakinolide or the PI3K inhibitors. In
addition, there is a good temporal and spatial association
between PtdIns(3,4,5)P3 production, as determined by
PH-GRP1-GFP binding, and actin filament depolymeriza-
tion. Thus, leptin and insulin signalling in, at least some
sub-groups of hypothalamic neurones maintains a close
parallel with leptin signalling in insulin-secreting cells,
where it has been reported that leptin increases KATP activ-
ity by a PI3K-dependent cortical actin re-arrangement
[47].
Conclusions
The effect of leptin and insulin on the phosphorylation
status of various cellular signalling intermediates and on
KATP channel activation in arcuate neurones indicates that
both hormones activate the same signalling cascades, and
can produce common outputs. The sensitivity of both
KATP opening and the phosphorylation of certain interme-
diates to PI3K inhibition is significant as this enzyme has
been previously demonstrated to play an important role
in leptin and insulin mediated energy homeostasis con-
trol. Furthermore it is interesting that leptin and insulin
induce rapid phosphorylation of MAPK and STAT3 as
these data support the view that these hormones may
influence genomic and membrane neuronal outputs by
common mechanisms. The inhibition of leptin and insu-
lin stimulation of KATP channel opening of arcuate neu-
rones by jasplakinolide suggests a role for cytoskeletal
dynamics in modulation of membrane events such as
neuronal hyperpolarization. This hypothesis is further
strengthened by the finding that leptin induces actin fila-
ment depolymerization in a mouse hypothalamic cell
line, which is PI3K dependent, demonstrating that this
cell line may be a useful model for further analysis of lep-
tin signalling mechanisms in hypothalamic neurones.
Methods
Preparation of hypothalamic lysates and immunoblots
Male Sprague-Dawley rats (50–100 g) were killed by cer-
vical dislocation in accordance with Schedule 1 of the UK
Government Animals (Scientific Procedures) Act (1986).
The brain was rapidly transferred to ice-cold aCSF solu-
tion, containing (in mM): 128 NaCl, 5 KCl, 1.2 NaH2PO4,
26 NaHCO3, 1.2 CaCl2, 2.4 MgSO4, and 10 glucose, equil-
ibrated with 95% O2, 5% CO2 to give a pH of 7.4. The tis-
sue was maintained in ice-cold aCSF whilst horizontal
400 Pm coronal brain slices were prepared using a
Vibratome (Intracel, Royston, Herts. UK). Slices contain-
ing the ARC were incubated in aCSF at room temperature
for 20 minutes, and then at 33–35°C for 1 hour. Hypoth-
alamic wedges, predominantly containing the ARC were
cut, and these were incubated in aCSF ± hormones and/or
kinase inhibitors (10 mls) for the required time. The reac-
tion was stopped by the addition of 2 ml of cold lysis
buffer containing (in mM) 100 NaCl, 10 NaF, 25 Tris HCl,
10 NaPPi, 5 EGTA, 1 EDTA, 1 Na3VO4, 1 Benzamidine, 0.1
PMSF, 0.1% (v/v) mercaptoethanol, 1% Tritron X-100 (v/
v) and 92 mg ml-1 sucrose. The tissue was homogenised
on ice, the lysate sonicated for two 10 s periods and then
centrifuged for 10 minutes at 12000 rpm at 4°C. The
supernatant was retained and the pellet discarded. The
protein content of the clarified lysate was determined by
the method of Bradford [49]. Proteins (10 Pg) were sepa-
rated by SDS-PAGE, and subsequently transferred to
nitrocellulose membranes. Membranes were incubated in
blocking buffer (10% non-fat dried milk in TBST (20 mM
Tris HCl, 150 mM NaCl, 0.5% Tween, pH 7.4)) for 1 hour
at room temperature following which phospho-specific
p44/p42 MAPK (Thr202/Tyr204), phospho-specific
STAT3 (Tyr705), phospho-specific GSK-3D/E(Ser21/9),
phospho-specific PKB (Thr308) and PKB (all polyclonal
and used at 1:1000) antibodies were applied overnight at
4°C with gentle shaking. All antibodies were obtained
from Cell Signalling Technology Inc. The membranes
were washed four times with TBST and incubated for 1
hour at room temperature with horseradish peroxidase
conjugated Goat anti-Rabbit IgG (1:5000). After further
washing with TBST, total amount of specific protein was
visualised by enhanced chemiluminescence detection as
described by the manufacturer (NEN Life Science Prod-
ucts). Immunoreactive bands were scanned and quanti-
fied using AIDA software. As an internal control, the
membranes were immunoblotted with a monoclonal anti
E-actin antibody (Sigma: used at 1:5000) or with the PKB
antibody. The values for proteins were normalized with
respect to the internal control to account for variations in
gel loading.
Determination of PI 3-kinase activity
Cell and tissue lysates were made as described. The immu-
noprecipitation and PI3K activity assay were carried out as
previously described [50]. Briefly, frozen samples were
thawed before centrifugation to remove precipitated
material. 10 Pl Protein-G-Sepharose beads pre-coupled to
5 Pg anti-IRS2 antibody (Upstate Biotechnology) was
used to immunoprecipitate PI3K activity from ~0.5 mg
cell lysate. The immunoprecipitated material was washed
once with ice cold lysis buffer and three times with ice
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cold assay buffer, both of which were freshly supple-
mented with protease inhibitors, reducing agent and
sodium vanadate as described [51]. Washed beads were
re-suspended in 40 Pl assay buffer supplemented with 1
PM unlabelled ATP, 25 PCi/assay radiolabelled ATP and
phosphatidylinositol/phosphatidylethanolamine vesicles
(final concentration of each lipid 100 PM). Samples were
incubated at 37°C for 30 mins and the reaction was
stopped by addition of 0.6 ml methanol/chloroform/12
M HCl (80:40:1, v/v), 0.2 ml chloroform and 0.32 ml 0.1
M HCl. Samples were processed and PtdIns(3)P separated
from contaminating materials by thin layer chromatogra-
phy (TLC) as previously described [51]. Bands corre-
sponding to [32P]PtdIns(3)P were located using a
phosphorimager (Fuji FLA 5000) and analyzed with AIDA
software.
Preparation of acutely isolated ARC neurones and 
electrophysiology
Coronal slices containing the medial hypothalamus were
obtained (as described above) and sections containing the
ARC were removed. The sections were transferred to 5 ml
aCSF containing 1 mg ml-1 protease XIV (Sigma-Aldrich,
Dorset, U.K) and incubated for 1 hour at room tempera-
ture. The aCSF was continuously gassed with 95% O2: 5%
CO2 for the entire incubation period. Sections were
removed and washed in 50 ml aCSF five times prior to re-
suspension in 5 ml normal saline containing (in mM):
135 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 3 glucose,
pH 7.4. Sections were sequentially triturated with fire pol-
ished Pasteur pipettes with decreasing tip size. The cell
suspension was evenly distributed onto concanavalin A
(Sigma-Aldrich) pre-treated 35 mm diameter culture
dishes. The culture dishes were left for 15–20 minutes
allowing cell adhesion prior to use.
Cell-attached single channel currents were recorded from
single neurones at room temperature, using an Axopatch
200B amplifier (Axon Instruments, Foster City, CA USA).
Patch pipettes were prepared from thick walled borosili-
cate glass and had open tip resistances of 8 – 15 M: when
filled with high K+ solution containing (in mM) 140 KCl,
1 MgCl2, 1 CaCl2, 10 HEPES, pH 7.2. This solution was
used in order to allow easy identification of K+ currents in
the cell-attached configuration [19]. All cell-attached
recordings were made in the presence of normal saline,
with no applied pipette potential, thus utilizing the cell
membrane potential to drive current flow (with inward
current shown as downward deflections). Single channel
recordings from inside-out patches isolated from ARC
neurones were made either under asymmetrical condi-
tions, in the presence of normal saline, or under symmet-
rical K+ conditions with the intracellular aspect of the
membrane exposed to a bathing solution containing (in
mM): 140 KCl, 1 MgCl2, 2.7 CaCl2, EGTA 10 (free Ca
2+ of
100 nM), HEPES 10, pH 7.2.
Data were recorded onto digital audio-tape using a Bio-
logic DTR 1200 recorder and analysed off-line. Pre-
recorded data were transferred via a Digidata 1200 inter-
face into a PC, digitised at 10 kHz and measured using the
PCLAMP6 software, Fetchan 6. The mean current (I) and
single channel amplitude (i) were determined for record-
ings ranging in duration from 30 s to 120 s and channel
activity (Nf.Po) determined as described previously [52],
where Nf is the number of functional channels and Po is
the open probability. Drug effects were measured by com-
parison of Nf.Po from individual patches in the presence
and absence of the drug. Data for a given set of experi-
ments were normalised and statistical significance deter-
mined by employing the Students t-test for unpaired data.
Results are presented as mean ± SEM and the number of
experiments denoted by 'n.'
Leptin receptor mRNA expression
Reverse transcription was performed in a 20 Pl reaction
containing 1 × First Strand Buffer, 1 mM DTT, 0.5 mM of
dNTP, 0.5 Pg anchored oligo(dT)18, 4 Pg RNA and 1 Pl
(200 U) M-MLV Reverse Transcriptase (Gibco), at 25°C
for 5 minutes, 42°C for 60 minutes, 70°C for 15 minutes
and stored at -20°C. After RT, a 2 Pl aliquot of the reaction
was added to 48 Pl of PCR mix. The mix containing 1 ×
PCR buffer, 2.5 mM MgCl2, 0.5 mM PCR nucleotide mix,
1 PM each of the gene specific primers (mObRcom
F:ggaatgagcaaggtcaaaa; mObRcom R:gtgacttccatatgcaaacc;
mObRb F:tcttctggagcctgaacccatttc; mObRb R:ttctcaccagag-
gtccctaaact; ref [53]) and 5 units of Taq DNA polymerase
(Promega). PCR was performed using the following pro-
file: 94°C for 5 minutes, 25 cycles at 94°C for 30 seconds,
55°C for 30 seconds, 72°C for 30 seconds, with a final
extension at 72°C for 7 minutes.
GT1-7 cell culture, staining and actin analysis
The mouse hypothalamic cell line GT1-7 [54] was grown
in Dulbecco's modified Eagle's medium supplemented
with 10% fetal calf serum (Sigma), 1 mM L-glutamine and
1% penicillin-streptomycin at 37°C in a humidified
atmosphere of 95% air and 5% CO2. Cells were passaged
every 3–4 days, plated on poly-L-lysine (Sigma) coated
glass coverslips in 3.5 cm Petri dishes and used 1–2 days
after plating. Cells were treated with 10 PM LY294002 or
10 nM wortmannin or 100 nM jasplakinolide (all Sigma)
in normal saline for 10 minutes, prior to a challenge with
10 nM leptin (or saline), in the continuous presence of
inhibitor, for 20 or 60 minutes before fixing. GT1-7 cells
were fixed in 4% methanol-free formaldehyde in cytoskel-
etal buffer (10 mM MES, 3 mM MgCl2, 138 mM KCl, 2
mM EGTA, pH 6.1) with 0.32 M sucrose for 30 minutes
[28]. They were then washed in phosphate-buffered saline
BMC Neuroscience 2004, 5:54 http://www.biomedcentral.com/1471-2202/5/54
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(PBS), permeabilised in PBS/0.5% Triton X-100 for 10
minutes, rinsed in PBS, blocked with 20% goat serum
(Sigma) for 30 minutes, rinsed in PBS and incubated with
rhodamine conjugated phalloidin, or 2 Pg ml-1 Alexa 594-
DNase I and 2 U ml-1 Alexa 488-phalloidin (all Molecular
Probes) for 90–120 minutes, rinsed in PBS, and mounted
on coverslips. Cells were observed with a 63X oil objective
and images acquired using a laser-scanning confocal
microscope (Zeiss LSM 510), under identical conditions
with randomly selected regions of each coverslip. For
quantitative analysis of G- and F-actin cellular pools, we
used a direct method to partition the actin pools from live
cells [28]. In brief, equal cell numbers were added to 3.5
cm culture dishes and cells grown to 80% confluence. The
Triton-X-100 soluble (G-actin) pool was isolated first, by
incubating cells for 5 minutes at room temperature with 1
ml PBS containing 1% Triton-X-100, protease inhibitors
and 1 Pg ml-1 phalloidin (to prevent filament dissocia-
tion). Cells were then washed with PBS, and the Triton-X-
100 insoluble pool (F-actin) prepared by addition of 1 ml
of PBS lysis buffer, containing 1% Triton-X-100, protease
inhibitors, 2% SDS and 1 Pg ml-1 phalloidin for 5 minutes
prior to harvesting cells from dishes. For determination of
total actin, cells were exposed to the second step only.
Each cellular pool was passed through a 25 gauge needle
and total protein concentration determined, before equal
amounts of protein were loaded onto SDS-PAGE gels, and
actin detected using an actin monoclonal antibody
(Chemicon). Quantitative measurements of G- and F-
actin in fixed cells were made using Velocity software
(Improvision), where individual cell total fluorescence,
normalized to cell area, was determined and background
fluorescence subtracted. Average fluorescence intensity
was calculated for 8 cells in each experiment, and
expressed relative to control (non-drug exposed cells).
Actin bands on gels were quantified by densitometry,
where total density was determined with respect to con-
stant area, background subtracted and average relative
band density calculated.
PH-GRP1-GFP fusion protein overlays
Following stimulation with hormone for 10–20 minutes,
acutely isolated neurones (room temperature) or GT1-7
cells (37°C) were fixed at room temperature with 2–4%
paraformaldehyde for 15 and 30 mins, respectively. Cells
were permeabilized by washing with 0.05% PBS-Tween
20 (PBS-T; x2 for 10 mins). Non-specific binding was
minimised by blocking with 3% BSA for 1 hour at room
temperature. Cells were subsequently washed with 0.05%
PBS-T prior to incubation with wild type PH-GRP1-GFP or
K273A mutant PH-GRP1-GFP (50 Pg ml-1) fusion protein
for 1 hour at room temperature, and images acquired by
confocal microscopy.
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